FICARRA, Paola
 Distribuzione geografica
Continente #
EU - Europa 6.364
NA - Nord America 5.502
AS - Asia 3.093
SA - Sud America 955
AF - Africa 94
Continente sconosciuto - Info sul continente non disponibili 45
OC - Oceania 10
Totale 16.063
Nazione #
US - Stati Uniti d'America 5.428
RU - Federazione Russa 3.036
SG - Singapore 1.355
CN - Cina 959
IE - Irlanda 842
BR - Brasile 841
SE - Svezia 712
UA - Ucraina 479
DE - Germania 388
HK - Hong Kong 356
GB - Regno Unito 229
FI - Finlandia 204
FR - Francia 193
IT - Italia 132
VN - Vietnam 98
IN - India 96
CA - Canada 43
AR - Argentina 36
TR - Turchia 34
PL - Polonia 31
ZA - Sudafrica 29
BD - Bangladesh 26
IQ - Iraq 26
ES - Italia 25
MA - Marocco 23
EC - Ecuador 22
IR - Iran 22
MX - Messico 21
PK - Pakistan 20
NL - Olanda 16
ID - Indonesia 14
AT - Austria 13
JP - Giappone 13
BE - Belgio 12
VE - Venezuela 12
CI - Costa d'Avorio 11
CO - Colombia 11
CZ - Repubblica Ceca 10
UZ - Uzbekistan 10
TN - Tunisia 9
CL - Cile 8
AU - Australia 7
AZ - Azerbaigian 7
PE - Perù 7
KE - Kenya 6
LV - Lettonia 6
OM - Oman 6
PH - Filippine 6
PY - Paraguay 6
UY - Uruguay 6
AE - Emirati Arabi Uniti 5
AL - Albania 5
DZ - Algeria 5
IL - Israele 5
MY - Malesia 5
NP - Nepal 5
RS - Serbia 5
SA - Arabia Saudita 5
ET - Etiopia 4
RO - Romania 4
BO - Bolivia 3
CH - Svizzera 3
JO - Giordania 3
LT - Lituania 3
MD - Moldavia 3
SN - Senegal 3
AM - Armenia 2
BN - Brunei Darussalam 2
BY - Bielorussia 2
EG - Egitto 2
EU - Europa 2
GR - Grecia 2
JM - Giamaica 2
LB - Libano 2
NZ - Nuova Zelanda 2
PA - Panama 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
SR - Suriname 2
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BS - Bahamas 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
DM - Dominica 1
GE - Georgia 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
KG - Kirghizistan 1
KR - Corea 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MK - Macedonia 1
MN - Mongolia 1
NG - Nigeria 1
NO - Norvegia 1
Totale 16.015
Città #
Moscow 938
Jacksonville 895
Dublin 841
Singapore 658
Ashburn 623
Chandler 530
Nyköping 429
Dallas 385
Hong Kong 355
Beijing 285
San Jose 232
Dearborn 190
Cambridge 139
Princeton 139
Medford 132
The Dalles 129
Lauterbourg 124
Des Moines 115
Los Angeles 109
Boardman 94
Lancaster 78
Council Bluffs 73
Buffalo 71
São Paulo 67
Ann Arbor 59
Jinan 59
Tianjin 59
Munich 54
Woodbridge 50
New York 45
Ho Chi Minh City 43
Guangzhou 42
Turku 38
Wilmington 38
Shenyang 35
Redondo Beach 30
San Mateo 26
Augusta 25
Houston 25
Atlanta 24
Belo Horizonte 24
Montreal 24
Rio de Janeiro 24
Warsaw 24
Frankfurt am Main 23
Hangzhou 23
Helsinki 23
Nanjing 23
Pune 23
Brasília 22
Brooklyn 21
Santa Clara 21
Chennai 20
Nanchang 19
Orem 19
Ardabil 18
Haikou 18
Leawood 18
Bremen 17
Zhengzhou 16
Campinas 15
Phoenix 15
Hebei 14
Mumbai 14
Rome 14
Denver 13
Hanoi 13
Johannesburg 13
Vienna 13
Brussels 12
Chicago 12
Seattle 12
Tokyo 12
Abidjan 11
London 11
Manchester 11
Messina 11
Ningbo 11
Porto Alegre 11
Shanghai 11
Taizhou 11
Amsterdam 10
Goiânia 10
Manaus 10
Poplar 10
San Francisco 10
Shenzhen 10
Auburn Hills 9
Boston 9
Fortaleza 9
Fuzhou 9
Guayaquil 9
Mexico City 9
Tashkent 9
Washington 9
Brno 8
Stockholm 8
Ankara 7
Baghdad 7
Casablanca 7
Totale 9.132
Nome #
Anticonvulsant agent: enhancement of physicochemical properties 201
AMPHIPHILIC CYCLODEXTRINS AS NANOCARRIERS OF GENISTEIN: A SPECTROSCOPIC INVESTIGATION POINTING OUT THE STRUCTURAL PROPERTIES OF THE HOST/ ISOFLAVONE COMPLEX SYSTEM IN WATER AND AT THE SOLID STATE 194
An experimental design methodology applied to the enantioseparation of a non-steroidal anti-inflammatory drug candidate 192
Combined effect of pH and polysorbates with cyclodextrins on solubilization of naringenin 182
ANALYSES AND DETERMINATION OF LONIDAMINE RELEASE FROM PHARMACEUTICAL FORMULATION. 178
BETA-BLOCKERS CHARACTERIZATION BY UV-VIS ABSORPTION AND REFLECTIVITY IN DIFFERENT CHEMICAL ENVIRONMENTS 173
Study of beta-blockers/beta-cyclodextrins inclusion complex by NMR, DSC, X-ray and SEM investigation 172
ANALYSIS OF PYRROLIDONIC COMPOUNDS AS POTENTIAL ANTIOXIDANT. 172
CARATTERIZZAZIONE DI COMPLESSI D'INCLUSIONE FLAVONOIDI/CICLODESTRINE MEDIANTE:DSC,RAGGI X,DRIFT,UV-VIS 171
A CHEMOMETRIC APPROACH FOR THE SEPARATION OF SOME PSYCHOTROPIC DRUGS AND THEIR METABOLITES BY LIQUID CHROMATOGRAPHY 171
Comparative photodegradation studies on 3-hydroxyflavone: influence of different media, pH and light sources 171
Amphiphilic Cyclodextrins as Nanocarriers of Genistein: aSpectroscopic Investigation Pointing out the StructuralProperties of the Host/Drug Complex System 170
COMBINED EFFECT OF pH AND CYCLODEXTRINS ON SOLUBILIZATION OF NARINGENIN 167
Analytical profile and release of lonidamine from pharmaceutical formulation 167
A STUDY OF THE INCLUSION COMPLEX OF ATENOLOL WITH BETA-CYCLODEXTRIN 166
CORDIA FRANCISCI, C, MARTINICENSIS, C. MYXA, C. SERRATIFOLIA AND C. ULMIFOLIA LEAVES AS NEW SOURCES OF RUTIN: ANALGESIC AND ANTI-INFLAMMATORY ACTIVITY. 166
AN EXPERIMENTAL DESIGN METHODOLOGY APPLIED TO THE CHIRAL SEPARATION OF A NON-STEROIDAL ANTI-INFLAMMATORY DRUG CANDIDATE 162
The rutin/beta-cyclodextrin interactions in fully aqueous solution: spectroscopic studies and biological assays 162
COMPARATIVE PHOTODEGRADATION STUDIES: INFLUENCE OF DIFFERENT MEDIA AND LIGHT SOURCES 158
PHYSICO-CHEMICAL CHARACTERIZATION OF AN AMPHIPHILIC CYCLODEXTRIN/GENISTEIN COMPLEX 156
CHROMATOGRAPHIC INVESTIGATIONS ON BROTIZOLAM 155
Cromatografia liquida ad alta efficienza nell'analisi farmaceutica: separazione e determinazione di una miscela diuretica-antipertensiva 154
ENANTIOSEPARATION AND COMPLEXATION STUDIES ON 2,3-BENZODIAZEPINES 154
Direct separation of the enantiomers of reboxetine by liquid chromatography on different cellulose- and amylose-based chiral stationary phases 152
CONFORMATIONAL SEARCH OF PHENYL SUBSTITUTED GAMMA-LACTAMIC DERIVATIVES. 152
PREPARATION AND CHARACTERIZATION OF GEMCITABINE-LOADED CHITOSAN MICROSPHERES. 152
ANALISI DI FLUNARIZINA BICLORIDRATO IN FORME FARMACEUTICHE MEDIANTE CROMATOGRAFIA LIQUIDA AD ALTA PRESSIONE 151
Optimization of a LC method for the enantio separation of a non-competitive glutamate receptor antagonist, by experimental design methodology 151
BROTIZOLAM: ANALISI E DETERMINAZIONE MEDIANTE TECNICHE CROMATOGRAFICHE. 151
INCAPSULATION OF LUTEIN IN AMPHIPHILIC -CYCLODEXTRIN NANOPARTICLES FOR THE APPLICATION IN DRUG DELIVERY. 151
SEPARAZIONE E DETERMINAZIONE MEDIANTE HPLC IN FASE INVERSA DI DERIVATI DEL 2-FENILCROMONE E DELL'ACIDO CLOROGENICO DA ESTRATTI DI CRATAEGUS OXYACANTHA L. 147
Gemcitabine-Loaded Chitosan Microspheres For Local Delivery In Lung, 147
UV-vis and FTIR-ATR characterization of 9-fluorenon-2-carboxyester/(2-hydroxypropyl)-beta-cyclodextrin inclusion complex 146
Synthesis, Chiral Resolution and Pharmacological Evaluation of a 2,3-Benzodiazepine-Derived Noncompetitive AMPA Receptor Antagonist 145
REAZIONI UV-INDOTTE:FOTOCHIMICA DI COMPLESSI D'INCLUSIONE FLAVONOIDI/CICLODESTRINE. Nota II 144
RUTIN INCLUSION SYSTEMS WITH ALFA AND BETA-CYCLODEXTRINS: CIRCULAR DICHROISM, UV ABSORPTION SPECTROSCOPY AND ANTIOXIDANT ACTIVITY STUDIES 144
Phisicochemical characterization of cumestrol beta-cyclodextrins inclusion complexes by UV-Vis anf FTIR-ATR spectyroscopies 142
OPTIMIZED ENANTIOSELECTIVE HPLC METHOD FOR THE ANALYSIS OF TETRAHYDROISOQUINOLINES 141
GEMCITABINE-LOADED CHITOSAN MICROSPHERES FOR LOCAL DELIVERY IN LUNG 139
SPECTROSCOPIC INVESTIGATION OF INCLUSION COMPLEX OF 9-FLUORENONIC DERIVATIVE WITH (2-HYDROXYPROPYL)-BETA-CYD 139
Variable-ionic strength kinetic experiments in drug stability studies 138
Physicochemical characterization of coumestrol/beta-cyclodextrins inclusion complexes by UV-vis and FTIR-ATR spectroscopies 138
INCLUSION COMPLEXES OF SOME FLAVANONES AND THEIR GLYCOSIDES WITH MODIFIED BETA-CYLODEXTRINS 137
Study of the extraction procedure by experimental design and validation of a LC method for determination of flavonoids in Citrus bergamia juice 135
NANOAGGREGATES OF AMPHIPHILIC CYCLODEXTRIN WITH GENISTEIN: A SPECTROSCOPY CHARACTERISATION BY UV-VIS, DYNAMIC LIGHT SCATTERING AND FTIR-ATR 135
Determination of fludarabine in a pharmaceutical formulation by LC 134
HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY. SEPARATION AND IDENTIFICATION OF FLAVONOIDS IN CRATAEGUS OXYACANTHA L. Note IV. Apigenin, Apigenin-7-glucoside, Luteolin, Luteolin-3',7-diglucoside 127
Effects of alpha and beta-cyclodextrin complexation on the physico-chemical properties and antioxidant activity of some 3-hydroxyflavones 127
Improvement in solubility and dissolution rate of flavonoids by complexation with beta-cyclodextrin 124
MISURE DI LIPOFILICITA' DI FLAVONI MEDIANTE CROMATOGRAFIA LIQUIDA IN FASE INVERSA 122
Study of the inclusion complex of atenolol with beta- cyclodextrins 121
Selective reversed-phase liquid chromatography method for the kinetic investigation of 3-hydroxyflavone photostability 120
MOLECULAR MODELING OF ENANTIOSELECTIVE RECOGNITION BETWEEN GAMMA-LACTAMIC DERIVATIVES AND CHIRALCEL OD CHIRAL STATIONARY PHASE. 119
Determinazione del trans-1-bis(4-fluorofenil)metil-4-(3-fenil-2-propenil)piperazina dicloridrato mediante HPLC 119
Cromatografia liquida nell'analisi farmaceutica: determinazione nelle compresse della famotidina, nuovo H2-antagonista 118
Photochemistry of flavonoids. Solvent effect on photochemical behaviour of 3-hydroxyflavone. 118
ISOFLAVONES AND CYCLODEXTRINS: EVIDENCES OF COMPLEXATION BY COMPLEMENTARY SPECTROSCOPIC TECHNIQUES 118
UV-INDUCED REACTIONS:EFFECTS OF MICROENVIROMENT ON FLAVONOIDS PHOTOCHEMISTRY 117
PREPARATION AND CHARACTERIZATION OF GEMCITABINE-LOADED CHITOSAN MICROSPHERES 117
The inclusion complexes of hesperetin and its 7-rhamnoglucoside with (2-hydroxypropyl)-beta-cyclodextrin 116
TECNICHE CHEMOMETRICHE PER L'OTTIMIZZAZIONE DI METODOLOGIE STRUMENTALI IN ANALISI FARMACEUTICA 115
Temperature-rate profiles by polarimetric variable-temperature kinetic experiments to study racemization reactions 115
Dosaggio mediante HPLC di atenololo e clortalidone associati in forme farmaceutiche 113
CROMATOGRAFIA LIQUIDA NELL'ANALISI FARMACEUTICA: SEPARAZIONE E DETERMINAZIONE DI FAMOTIDINA, NUOVO H2-ANTAGONISTA 110
METAL-COMPLEXES OF BENZODIAZEPINES . PART 2. THE REACTION OF 1,4- BENZODIAZEPINES WITH HALIDE-BRIDGED COMPLEXES OF PALLADIUM(II) [PD2X4(PPRN3)2] (X = CL OR I) 109
DIRECT ENANTIOMERIC SEPARATION OF REBOXETINE BY LIQUID CHROMATOGRAPHY USING DIFFERENT CELLULOSE AND AMYLOSE BASED CHIRAL STATIONARY PHASES 108
Diastereo-enantioseparation of N-Acetyl-1-aryl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline derivatives on cellulose chiral stationary phases 107
STRUCTURAL AND CONFORMATIONAL STUDY OF BETA-BLOCKERS/BETA-CYCLODEXTRIN COMPLEXES 105
PROFILI TEMPERATURA-VELOCITA' DA CINETICHE POLARIMETRICHE A TEMPERATURA VARIABILE 105
HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY AND DIFFUSE REFLECTANCE SPECTROSCOPY OF FLAVONOIDS IN CRATEGUS-OXYACANTHA L .3. ANALYSIS OF 2-PHENYL-CHROMAN DERIVATIVES AND CAFFEIC ACID 105
CROMATOGRAFIA LIQUIDA AD ALTA RISOLUZIONE NELL'ANALISI DI PREPARAZIONI ESTRATTIVE DI FOGLIE E GERMOGLI DI OLEA EUROPAEA L. 104
PHOTODEGRADATION STUDY ON 3-HYDROXYFLAVONE BY HPLC. 104
FLUORIMETRIC STUDY OF b-BLOCKERS/b-CYCLODEXTRINS INCLUSION COMPLEXES 103
FTIR-ATR spectroscopy to probe selective protein recognition by cyclodextrin nanoaggregates 103
PHARMACEUTICAL APPLICATION OF BETA-CYCLODEXTRIN: INCLUSION COMPLEXES WITH BETA-BLOCKERS 103
FORCE FIELD COMPARISONS AND CONFORMATIONAL ANALYSIS OF STRUCTURES INTERESTING IN PHARMACEUTICAL RESEARCH. 100
Diastereo-enantioseparation of novel gamma-lactamic derivatives on cellulose chiral stationary phases 99
STRUCTURAL AND THERMODYNAMIC STUDY OF BETA-BLOCKERS/BETA-CYCLODEXTRIN INCLUSION COMPLEXES 99
Nuclear magnetic resonance of psychotherapeutic agents. IV. Conformational analysis of 2,3-dihydro.1H-1,4-benzodiazepines 99
Dosaggio HPLC della roxatidina, prove di stabilità e rilascio da formulazioni farmaceutiche. 98
ENANTIOMERIC SEPARATION BY HPLC OF FLAVANONES AND FLAVANS WITH ANTIOXYDANT ACTIVITY. 98
VALIDATION OF A LIQUID CROMATOGRAPHIC METHOD FOR THE ANALYSIS OF ZAFIRLUKAST IN A PHARMACEUTICAL FORMULATION 97
MODIFIED CYCLODEXTRINS IN THE SOLUBILIZATION OF SOME PHYTOESTROGENS 97
HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY OF FLAVONOIDS IN CRATAEGUS-OXYACANTHA L .4. REVERSED-PHASE HIGH-PRESSURE LIQUID- CHROMATOGRAPHY IN FLOWER, LEAF AND BUD EXTRACTIVES OF CRATAEGUS-OXYACANTHA L 97
Nuclear magnetic resonance of 1,4-benzodiazepines. II. Stereochemistry of 1,3-dihydro-2H-1,4-benzodiazepin-2-ones by lanthanide shift reagents 97
VALIDATION OF A LC METHOD FOR THE ANALYSIS OF OXALIPLATIN IN A PHARMACEUTICAL FORMULATION USING EXPERIMENTAL DESIGN 96
SIMULTANEOUS DETERMINATION OF METAPROLOL AND HYDROCLOROTHIAZIDE IN TWO COMPONENT TABLET FORMULATIONS BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY 95
IMPROVEMENT OF FLAVONOIDS DISSOLUTION PROPERTIES BY COMPLEXATION WITH BETA-CYCLODEXTRIN 95
Isolation and characterization of Guiera senegalensis J.F.Gmel. active principles. 95
Nuclear magnetic resonance spectra of psychotherapeutic agents. V. Conformational analysis of 1,3,4,5-tetrahydro-2H-1,5-benzodiazepin-2-ones 94
Validation of variable-parameter kinetic methods for accelerated studies on drug stability 93
HPLC-DAD AND TLC OF FLAVONOIDS FROM LEAF EXTRACTIVES OF GENUS CORDIA. 93
STUDIO COMPARATIVO DI RISOLUZIONE ENANTIOMERICA DI NUOVI DERIVATI 2,3-BENZODIAZEPINICI AD ATTIVITA' ANTICONVULSIVANTE SU FASI STAZIONARIE CHIRALI DI NATURA POLISACCARIDICA. 93
USE OF DIFFERENT CYCLODEXTRINS AS SOLUBILIZING AGENTS 92
STRUCTURE OF BETA-BLOCKERS/BETA-CYCLODEXTRIN INCLUSION COMPLEX BY NMR, X-RAY AND DSC INVESTIGATION 92
MODELLO DI INTERAZIONE SELECTORS-SELCTANDS NEL PROCESSO DI DISCRIMINAZIONE CHIRALE. 92
SOLUBILIZATION OF NARINGENIN BY COMBINED CONTROL OF SURFACTANT AND CYCLODEXTRIN 91
Risonanza magnetica nucleare di 1,4-benzodiazepine. Accoppiamento attraverso lo spazio di 2,3-diidro-1H-1,4-benzodiazepine 1-sostituite 91
LC/MS SELECTIVE SCREENING OF SOME BETA-BLOCKERS IN HUMAN URINE SAMPLES AND ITS POTENTIAL USE IN DOPING CONTROL 90
LEAF EXTRACTS OF SOME CORDIA SPECIES - ANALGESIC AND ANTIINFLAMMATORY ACTIVITIES AS WELL AS THEIR CHROMATOGRAPHIC ANALYSIS 90
Totale 12.890
Categoria #
all - tutte 54.757
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.757


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022961 0 210 10 14 21 2 66 40 4 118 177 299
2022/20232.415 175 179 123 155 216 235 38 137 1.032 10 92 23
2023/2024411 65 75 34 50 39 81 6 14 0 16 2 29
2024/20252.313 36 36 38 157 88 40 39 517 585 126 217 434
2025/20266.820 347 406 475 493 587 1.627 946 731 768 241 102 97
2026/2027140 119 21 0 0 0 0 0 0 0 0 0 0
Totale 16.063